Pulmonary and critical care ·
Olympus launches slim peripheral EBUS scope; CGM tracks point-of-care glucose in surgery and ICU; digital outreach reaches 11% for lung screening
Listen to this post
read by AI voices · all episodesTHE SHORT READ
Olympus said Oct. 15 that it launched in the U.S. a slim endobronchial ultrasound bronchoscope with a 5.9 mm outer diameter at the distal end, designed to reach segmental and sub-segmental airways.
A British Journal of Anaesthesia study found 98% of paired continuous glucose monitoring and point-of-care readings in perioperative and intensive care patients with diabetes fell within clinically acceptable error grid zones, and a digital outreach program reached 11% of 26,909 people invited to check lung cancer screening eligibility.
THE DETAILS
- Technology Oct 15, 2026Olympus said Oct. 15 that it launched in the U.S. the BF-UCP190F, a slim endobronchial ultrasound (EBUS) bronchoscope with an outer diameter of 5.9 mm at the distal end, designed to reach deeper lung regions such as segmental and sub-segmental airways. The scope has an upward angulation of 170 degrees and is compatible with the ViziShot 2 25G EBUS-TBNA needle, according to the company. Thomas Gildea, Olympus' global lead for respiratory medical affairs, said extending EBUS beyond the central airway is "an important new tool."Source: Olympus
- Research Oct 12, 2026A prospective observational study published Oct. 12 in the British Journal of Anaesthesia compared a Dexcom G7 continuous glucose monitor (CGM) with point-of-care measurements in 58 people with diabetes in the perioperative and intensive care setting. The median absolute relative difference (MARD), the primary end point, was 10.9%, and 1,186 of 1,212 paired measurements (98%) fell within clinically acceptable Clarke error grid zones A and B. MARD was 4.5% higher (95% CI 2.3% to 6.7%) during periods of hypoperfusion, the authors reported.Source: British Journal of Anaesthesia
- Research Oct 13, 2026A secondary analysis of a pragmatic randomized trial, published Oct. 13 in the Journal of General Internal Medicine, found that 3,049 of 26,909 people invited (11%) completed lung cancer screening eligibility questions within 16 weeks through digital outreach. Reach was higher among White participants than among Black and Hispanic participants (12.8% versus 8.6% and 8.0%). Sending text invitations to people not reachable by patient portal expanded reach by 604 participants, the authors reported.
The weekly innovation roundup for pulmonary and critical care, published every Sunday for the week before; every item links to its sources. Latest pulmonary and critical care news · All specialties